tiprankstipranks
Citius Oncology (CTOR)
NASDAQ:CTOR
US Market

Citius Oncology (CTOR) Financial Statements

Compare
63 Followers

Citius Oncology Financial Overview

Citius Oncology's market cap is currently $85.86M. The company's EPS TTM is $-0.078; its P/E ratio is ―; Citius Oncology is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Sep 24Sep 23Sep 22
Income Statement
Total Revenue$ 0.00$ 0.00$ 0.00
Gross Profit$ 0.00$ 0.00$ 0.00
Operating Income$ -20.57M$ -12.12M$ -4.86M
EBITDA$ -20.57M$ -12.12M$ -4.86M
Net Income$ -21.15M$ -12.70M$ -5.43M
Balance Sheet
Cash & Short-Term Investments$ 112.00$ 0.00$ 0.00
Total Assets$ 84.37M$ 47.73M$ 42.69M
Total Debt$ 3.80M$ 0.00$ 0.00
Net Debt$ 3.80M$ 0.00$ 0.00
Total Liabilities$ 38.23M$ 22.20M$ 6.42M
Stockholders' Equity$ 46.14M$ 25.54M$ 36.27M
Cash Flow
Free Cash Flow$ -4.87M$ 0.00$ 0.00
Operating Cash Flow$ 126.35K$ 0.00$ 0.00
Investing Cash Flow$ -5.00M$ 0.00$ 0.00
Financing Cash Flow$ 4.87M$ 0.00$ 0.00
Currency in USD

Citius Oncology Earnings and Revenue History

Citius Oncology Debt to Assets

Citius Oncology Cash Flow

Citius Oncology Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis